Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity, Disclosure

v3.8.0.1
Stockholders' Equity, Disclosure
6 Months Ended
Jun. 30, 2017
Notes  
Stockholders' Equity, Disclosure

5.             STOCKHOLDERS’ EQUITY:

 

Stock Options

 

 

Number of Options

Weighted

Average

Exercise

Price

Weighted

Average

Remaining

Life (Years)

Balance, December 31, 2016

269,500

$ 1.88

2.04

Granted

--

$     --

--

Exercised

--

$     --

--

Cancelled

(32,000)

$ 1.75

--

Balance, June 30, 2017

237,500

$ 1.89

1.78

Exercisable, June 30, 2017

237,500

$ 1.89

1.78

 

The Company recognized no stock-based compensation expense during the three and six months ended June 30, 2017 and $1,629 and $6,691 during the three and six months ended June 30, 2016, respectively.

 

As of June 30, 2017, there is no unrecognized compensation expense related to the issuance of the stock options.

 

Performance Stock Options

 

There were no performance stock options granted during the three and six months ended June 30, 2017 and 2016.

 

 

Number of Options

 

Weighted

Average

Exercise

Price

Balance, December 31, 2016

40,000

 

$ 2.00

Granted

--

 

--

Exercised

--

 

--

Cancelled

--

 

--

Balance, June 30, 2017

40,000

 

$ 2.00

Exercisable, June 30, 2017

40,000

 

$ 2.00

 

Warrants

 

There were no warrants issued during the three and six months ended June 30, 2017.

 

 

Number of Warrants

Weighted

Average

Exercise

Price

Weighted

Average

Remaining

Life (Years)

Balance, December 31, 2016

2,000,304

$ 2.36

0.63

Granted

--

--

--

Exercised

--

--

--

Cancelled

(523,326)

$ 3.00

--

Balance, June 30, 2017

1,476,978

$ 2.13

0.30